Insiders · IPSC

IPSC insider transactions

Century Therapeutics Inc. (IPSC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IPSC

• 7d
  Officer Russotti Gregory sold $5,767 worth of shares (2,584 units at $2.23), decreasing direct ownership by 0.50% to 512,319 units (SEC Form 4) (for tax liability)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 7d
  SVP Finance & Operations Carr Douglas sold $3,692 worth of shares (1,654 units at $2.23), decreasing direct ownership by 0.33% to 505,094 units (SEC Form 4) (tax liability)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 7d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 13,849 shares, decreasing direct ownership by 0.38% to 3,665,474 units (SEC Form 4) (withholding tax)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 7d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 358 shares, decreasing direct ownership by 0.03% to 1,175,322 units (SEC Form 4) to satisfy withholding tax

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 10d
  SEC Form 4 filed by Director Riva Alessandro

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 10d
  SEC Form 4 filed by Director Quimi Daphne

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 10d
  SEC Form 4 filed by Director Murphy Martin Patrick

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 10d
  SEC Form 4 filed by Director Lee Han Myung

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 10d
  SEC Form 4 filed by Director Blackwell Kimberly

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 13d
  Officer Russotti Gregory sold $1,106 worth of shares (524 units at $2.11), decreasing direct ownership by 0.10% to 514,903 units (SEC Form 4) (withholding tax)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 13d
  SVP Finance & Operations Carr Douglas sold $526 worth of shares (249 units at $2.11), decreasing direct ownership by 0.05% to 506,748 units (SEC Form 4) (withholding obligation)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 13d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,679,323 units (SEC Form 4) (withholding obligation)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 34d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 31,172 shares, decreasing direct ownership by 0.84% to 3,679,786 units (SEC Form 4) to satisfy withholding tax

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 47d
  SVP Finance & Operations Carr Douglas sold $618 worth of shares (264 units at $2.34), decreasing direct ownership by 0.05% to 506,997 units (SEC Form 4) (for withholding tax)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 73d
  SEC Form 4 filed by Murphy Martin Patrick

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 73d
  SEC Form 3 filed by new insider Murphy Martin Patrick

  3 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 80d
  SEC Form 4 filed by Cowan Chad

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 98d
  SVP Finance & Operations Carr Douglas sold $17,953 worth of shares (7,043 units at $2.55), decreasing direct ownership by 1% to 507,261 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 98d
  Officer Russotti Gregory sold $25,684 worth of shares (10,076 units at $2.55), decreasing direct ownership by 2% to 515,427 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 101d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 55,397 shares, decreasing direct ownership by 1% to 3,710,958 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 101d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,431 shares, decreasing direct ownership by 0.12% to 1,177,045 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 103d
  SEC Form 4 filed by Century Therapeutics Inc.

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 103d
  SVP Finance & Operations Carr Douglas sold $626 worth of shares (247 units at $2.54), decreasing direct ownership by 0.05% to 514,304 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 104d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,766,355 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 124d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 31,172 shares, decreasing direct ownership by 0.82% to 3,766,818 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 137d
  SVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 138d
  President and CEO Pfeiffenberger Brent was granted 475,000 shares, increasing direct ownership by 14% to 3,797,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 138d
  Officer Russotti Gregory was granted 135,000 shares, increasing direct ownership by 35% to 525,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 138d
  Chief Scientific Officer Cowan Chad was granted 135,000 shares, increasing direct ownership by 13% to 1,178,476 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 138d
  SVP Finance & Operations Carr Douglas was granted 110,000 shares, increasing direct ownership by 27% to 514,874 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 167d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,611 shares, decreasing direct ownership by 0.15% to 1,043,476 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 175d
  Chief Scientific Officer Cowan Chad bought $49,252 worth of shares (58,060 units at $0.85), increasing direct ownership by 6% to 1,045,087 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 188d
  President and CEO Pfeiffenberger Brent bought $30,352 worth of shares (52,000 units at $0.58), increasing direct ownership by 2% to 3,322,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 192d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,270,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 193d
  SEC Form 4 filed by Director Lee Han Myung

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 193d
  SEC Form 3 filed by new insider Lee Han Myung

  3 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 194d
  SVP Finance & Operations Carr Douglas sold $137 worth of shares (257 units at $0.53), decreasing direct ownership by 0.06% to 404,874 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 194d
  Officer Russotti Gregory sold $280 worth of shares (526 units at $0.53), decreasing direct ownership by 0.13% to 390,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 210d
  Chief Scientific Officer Cowan Chad sold $2,736 worth of shares (5,462 units at $0.50), decreasing direct ownership by 0.55% to 987,027 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 214d
  President and CEO Pfeiffenberger Brent bought $17,328 worth of shares (35,000 units at $0.50), increasing direct ownership by 1% to 3,271,453 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 215d
  President and CEO Pfeiffenberger Brent sold $14,735 worth of shares (32,456 units at $0.45), decreasing direct ownership by 0.99% to 3,236,453 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 229d
  SVP Finance & Operations Carr Douglas sold $171 worth of shares (292 units at $0.59), decreasing direct ownership by 0.07% to 405,131 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 273d
  Chief Scientific Officer Cowan Chad was granted 762,543 shares, increasing direct ownership by 332% to 992,489 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 285d
  SVP Finance & Operations Carr Douglas sold $132 worth of shares (263 units at $0.50), decreasing direct ownership by 0.06% to 405,423 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 285d
  President and CEO Pfeiffenberger Brent sold $244 worth of shares (488 units at $0.50), decreasing direct ownership by 0.01% to 3,268,909 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 285d
  Officer Russotti Gregory sold $270 worth of shares (539 units at $0.50), decreasing direct ownership by 0.14% to 391,508 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 308d
  President and CEO Pfeiffenberger Brent was granted 1,587,614 shares, increasing direct ownership by 94% to 3,269,397 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 320d
  SVP Finance & Operations Carr Douglas sold $158 worth of shares (296 units at $0.53), decreasing direct ownership by 0.07% to 405,686 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Blackwell Kimberly

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Jimenez Joseph

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Riva Alessandro

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Carlo Rizzuto

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Quimi Daphne

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Butitta Cynthia M

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 371d
  SEC Form 4 filed by Director Walbert Timothy P

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 376d
  SVP Finance & Operations Carr Douglas sold $3,050 worth of shares (4,904 units at $0.62), decreasing direct ownership by 1% to 405,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 376d
  Chief Operations Officer Farid Adrienne sold $343 worth of shares (552 units at $0.62), decreasing direct ownership by 0.22% to 250,141 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 376d
  President and CEO Pfeiffenberger Brent sold $295 worth of shares (475 units at $0.62), decreasing direct ownership by 0.03% to 1,681,783 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 376d
  Officer Russotti Gregory sold $327 worth of shares (526 units at $0.62), decreasing direct ownership by 0.13% to 392,047 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 398d
  President and CEO Pfeiffenberger Brent sold $16,135 worth of shares (29,552 units at $0.55), decreasing direct ownership by 2% to 1,682,258 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)